Influenza Burden Assessment in the United States, July1997 - up to April 2009

GlaxoSmithKline (GSK)

Status: Completed

Conditions: Influenza

Treatments: Other: Data collection

Study type: Observational

Funder types: Industry

Identifiers

NCT01599390

116730

Details and patient eligibility

About

The study will assess the burden of severe influenza outcomes by age, risk status, and influenza subtype, in order to create a profile of the burden of influenza-related morbidity and mortality in United States from July 1997 to April 2009.

Full description

This epidemiological study is a modelling of time series retrospectively extracted from multiple databases. Data will be extracted from existing electronic healthcare databases.

Enrollment: 1 patient

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Recorded in the US NIS hospitalization data or the US National Vital Statistics System (NVSS) mortality data with a pre-specified diagnostic code.

Exclusion criteria

• Missing data in the following fields: age, primary discharge diagnosis, admission month (NIS) /month of death (NVSS), and status at discharge (alive / dead).

Trial design

1 participants in 1 patient group

Influenza Group

Treatment:

Other: Data collection